Suppr超能文献

BK病毒大T抗原ATP结合位点作为药物研发靶点的验证

Validation of BKV large T-antigen ATP-binding site as a target for drug discovery.

作者信息

Zeng Gang, Bueno Marta, Camachos Carlos J, Ramaswami Bala, Luo Chunqing, Randhawa Parmjeet

机构信息

Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Antiviral Res. 2009 Feb;81(2):184-7. doi: 10.1016/j.antiviral.2008.11.004. Epub 2008 Dec 11.

Abstract

BK virus large T antigen (LTA) is a hexameric protein with a helicase activity that is powered by ATP hydrolysis. A mutant virus with Lys420Ala, Arg421Ala, and Asp504Ala mutations at the ATP binding sites showed marked reduction in viral fitness. This observation indicates that high throughput screening for ATPase inhibitors will be valid strategy to discover anti-BKV drugs. Pilot screening of 300 compounds from the Tim Tec ActiTarg K library identified a compound, STO18584, with selectivity index of 19.2.

摘要

BK病毒大T抗原(LTA)是一种具有解旋酶活性的六聚体蛋白,其活性由ATP水解提供能量。一种在ATP结合位点发生赖氨酸420突变为丙氨酸、精氨酸421突变为丙氨酸以及天冬氨酸504突变为丙氨酸的突变病毒,其病毒适应性显著降低。这一观察结果表明,高通量筛选ATP酶抑制剂将是发现抗BK病毒药物的有效策略。对Tim Tec ActiTarg K文库中的300种化合物进行初步筛选,确定了一种名为STO18584的化合物,其选择性指数为19.2。

相似文献

4
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors.
J Med Chem. 2016 Aug 11;59(15):7138-51. doi: 10.1021/acs.jmedchem.6b00486. Epub 2016 Jul 20.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验